IDEAYA Biosciences, Inc. (IDYA) News
Track canonical SquawkNews coverage tagged to IDYA, IDEAYA Biosciences, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
IDYA IDYA - IDEAYA Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update
IDYA IDYA - IDEAYA Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update
EARNINGS | Aug 04, 2026, 10:00 AM UTC
L
IDEAYA Biosciences Announces Inducement Grants
IDEAYA Biosciences grants inducement awards
EQUITY | Jul 31, 2026, 10:00 AM UTC
L
IDYA Ideaya Biosciences announces ide892, a potential best-in-class mta-cooperative prmt5 inhibitor, initiates part 2 monotherapy expansion
IDYA Ideaya Biosciences announces ide892, a potential best-in-class mta-cooperative prmt5 inhibitor, initiates part 2 monotherapy expansion in the phase 1/2 study in mtap-deleted pancreatic and lung cancers
EQUITY | Jul 27, 2026, 10:27 AM UTC
L
Ideaya Biosciences Insider Sold Shares Worth $382,131, According to a Recent SEC Filing
() -- Briseno Andres Ruiz, Chief Accounting Officer, on July 07, 2026, sold 9,550 shares in Ideaya Biosciences (IDYA) for $382,131. Following the Form 4 filing with the SEC, Ruiz has control over a total of 26,466 common
REGULATION | Jul 09, 2026, 09:02 PM UTC